We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Top Sells

Rank Stock Value
1
VER
VEREIT, Inc.
VER
+$434M
2
CONE
CyrusOne Inc Common Stock
CONE
+$386M
3
WY icon
Weyerhaeuser
WY
+$118M
4
HR icon
Healthcare Realty
HR
+$68.6M
5
VTR icon
Ventas
VTR
+$64.7M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XERS icon
1426
Xeris Biopharma Holdings
XERS
$1.42B
$0 ﹤0.01%
102
– –
XNET
1427
Xunlei
XNET
$334M
– –
-13,431
Closed -$38K
XPO icon
1428
XPO
XPO
$24B
– –
-2,525
Closed -$119K
YUMC icon
1429
Yum China
YUMC
$15.6B
– –
-39,535
Closed -$2.3M
QTTB icon
1430
Q32 Bio
QTTB
$467M
$0 ﹤0.01%
6
– –
TECX
1431
Tectonic Therapeutic
TECX
$562M
$0 ﹤0.01%
7
– –
XIFR
1432
PUT
XPLR Infrastructure LP
XIFR
$1.11B
– –
-554
Closed -$140K
SYRS
1433
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
10
– –
TWOU
1434
DELISTED
2U Inc
TWOU
– –
-46
Closed -$46K
FUSN
1435
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-78
Closed -$1K
EIGR
1436
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$0 ﹤0.01%
2
– –
GMDA
1437
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$0 ﹤0.01%
93
– –
BCEL
1438
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-65
Closed –
ORTX
1439
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-1,326
Closed -$30K
LTHM
1440
DELISTED
Livent Corporation
LTHM
– –
-6,618
Closed -$153K
RVLP
1441
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-140
Closed –
PRTK
1442
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$0 ﹤0.01%
86
– –
SURF
1443
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$0 ﹤0.01%
77
– –
HARP
1444
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$0 ﹤0.01%
5
– –
SPPI
1445
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$0 ﹤0.01%
321
– –
CNCE
1446
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-58
Closed –
ATNX
1447
DELISTED
Athenex, Inc. Common Stock
ATNX
$0 ﹤0.01%
9
– –
EPZM
1448
DELISTED
Epizyme, Inc
EPZM
$0 ﹤0.01%
191
– –
CALA
1449
DELISTED
Calithera Biosciences, Inc
CALA
– –
-7
Closed –
KLDO
1450
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
– –
-68
Closed –
55 56 57
58
59

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.